- Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
- Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
- MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES
- MESA LABS DECLARES QUARTERLY DIVIDEND
- Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024
- Mesa Labs Releases Second Annual Responsible Business Program Brochure
- Mesa Laboratories Appoints Mark Capone to its Board of Directors
- Mesa Labs Completes the Acquisition of GKE Science & Technology Co.
- Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024
- Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa’s SDC Platform
More ▼
Key statistics
On Friday, Mesa Laboratories Inc (MLAB:NSQ) closed at 95.70, 15.50% above the 52 week low of 82.86 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 117.80 |
---|---|
High | 118.00 |
Low | 89.19 |
Bid | 91.00 |
Offer | 105.42 |
Previous close | 110.52 |
Average volume | 41.17k |
---|---|
Shares outstanding | 5.39m |
Free float | 5.08m |
P/E (TTM) | 546.42 |
Market cap | 516.21m USD |
EPS (TTM) | 0.1751 USD |
Annual div (ADY) | 0.64 USD |
---|---|
Annual div yield (ADY) | 0.67% |
Div ex-date | May 31 2024 |
Div pay-date | Jun 14 2024 |
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼